Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03949569 · ClinicalTrials.gov registry record · NA

The Effects of Therapy Dogs on Child Biology and Behavior

A NA study, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
188
Enrollment target

NCT03949569: Completed NA study, sponsored by University of Chicago.

NCT03949569 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 188 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03949569, a NA study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
188 participants
Enrollment target

Study Summary

The objective of this study is to apply a rigorous experimental design to test whether children's interactions with therapy dogs increase immediate prosocial behavior and reduce immediate biological response to stress.

Primary Outcome

Salivary cortisol will be collected 7 times during the study visit.

Interventions

  • BEHAVIORAL Therapy Dog
  • BEHAVIORAL Stuffed Toy Dog
  • BEHAVIORAL 5 Minute Puppy Video

Trial Details

FieldValue
Enrollment Target 188 participants
Start Date 2019-06-15
Est. Completion 2022-01-31
Phase NA
University of Chicago

796 total trials

What the finished NCT03949569 record still lists

NCT03949569 is an interventional study that assigns participants to a tested intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 3 interventions - of which Therapy Dog is the first listed.

NCT03949569 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03949569 about?

NCT03949569 is a clinical study titled "The Effects of Therapy Dogs on Child Biology and Behavior". The objective of this study is to apply a rigorous experimental design to test whether children's interactions with therapy dogs increase immediate prosocial behavior and reduce immediate biological response to stress.

What is the current status of trial NCT03949569?

This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2019-06-15. Estimated completion is 2022-01-31.

What interventions are being tested in trial NCT03949569?

The interventions under investigation include: Therapy Dog (BEHAVIORAL), Stuffed Toy Dog (BEHAVIORAL), 5 Minute Puppy Video (BEHAVIORAL).

Who is sponsoring clinical trial NCT03949569?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03949569's enrollment target sits among peer trials

188 576th of 2000 higher than 1,422 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422198 · 188 participants · Phase 3

    Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

  • NCT04469790 · 188 participants · NA

    Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children

  • NCT04671667 · 188 participants · Phase 2

    Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

  • NCT04853251 · 188 participants · Phase 4

    A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03949569, the US trial registry maintained by the National Library of Medicine. NCT03949569 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.